<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/CF9AA84F-ED5C-41C7-AE08-655128299AD1"><gtr:id>CF9AA84F-ED5C-41C7-AE08-655128299AD1</gtr:id><gtr:name>Nanoco</gtr:name><gtr:address><gtr:line1>48 Grafton Street</gtr:line1><gtr:line4>Manchester</gtr:line4><gtr:postCode>M13 9XX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/35DEDB45-AEE9-45B7-9503-ECF7C0625D2F"><gtr:id>35DEDB45-AEE9-45B7-9503-ECF7C0625D2F</gtr:id><gtr:name>Centric Lab (London) Ltd</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3DEE9344-B2E6-458C-B226-C421D52A62DF"><gtr:id>3DEE9344-B2E6-458C-B226-C421D52A62DF</gtr:id><gtr:name>Diabetes UK</gtr:name><gtr:address><gtr:line1>10 Parkway</gtr:line1><gtr:line2>Campden</gtr:line2><gtr:postCode>NW1 7AA</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CF9AA84F-ED5C-41C7-AE08-655128299AD1"><gtr:id>CF9AA84F-ED5C-41C7-AE08-655128299AD1</gtr:id><gtr:name>Nanoco</gtr:name><gtr:address><gtr:line1>48 Grafton Street</gtr:line1><gtr:line4>Manchester</gtr:line4><gtr:postCode>M13 9XX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/35DEDB45-AEE9-45B7-9503-ECF7C0625D2F"><gtr:id>35DEDB45-AEE9-45B7-9503-ECF7C0625D2F</gtr:id><gtr:name>Centric Lab (London) Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3DEE9344-B2E6-458C-B226-C421D52A62DF"><gtr:id>3DEE9344-B2E6-458C-B226-C421D52A62DF</gtr:id><gtr:name>Diabetes UK</gtr:name><gtr:address><gtr:line1>10 Parkway</gtr:line1><gtr:line2>Campden</gtr:line2><gtr:postCode>NW1 7AA</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/782A4DB8-9169-46F8-8C93-1EE564C0EE63"><gtr:id>782A4DB8-9169-46F8-8C93-1EE564C0EE63</gtr:id><gtr:firstName>David</gtr:firstName><gtr:surname>Miller</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/FA9DF4CA-FD5C-4EE5-A7EC-4EEDFFFFBE79"><gtr:id>FA9DF4CA-FD5C-4EE5-A7EC-4EEDFFFFBE79</gtr:id><gtr:firstName>Neil</gtr:firstName><gtr:surname>Millar</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/3AEB4C1F-38DA-4B07-8871-1DEBDF07BD1C"><gtr:id>3AEB4C1F-38DA-4B07-8871-1DEBDF07BD1C</gtr:id><gtr:firstName>Rachel</gtr:firstName><gtr:otherNames>Clare</gtr:otherNames><gtr:surname>Chambers</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/504F088E-0E6B-4549-97DC-62154A607BCB"><gtr:id>504F088E-0E6B-4549-97DC-62154A607BCB</gtr:id><gtr:firstName>Jane</gtr:firstName><gtr:surname>Kinghorn</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A32BD451-FBEB-4F05-BEE2-18D6B4FEAB77"><gtr:id>A32BD451-FBEB-4F05-BEE2-18D6B4FEAB77</gtr:id><gtr:firstName>Stephen</gtr:firstName><gtr:otherNames>Edward</gtr:otherNames><gtr:surname>Moss</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_PC_15063"><gtr:id>FD401981-239D-437A-A782-8CAC5D02D2A6</gtr:id><gtr:title>UCL Proximity to Discovery (PtoD) Fund 2015/16 Application</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_PC_15063</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>The MRC Proximity to Discovery scheme awards universities funds to help develop new collaborations, and ways of exchanging knowledge and skills.&amp;nbsp; The awards can be used to support activities that promote the value of academic-industry partnership, and enhance academic and industry researchers? understanding of each other?s needs and capabilities.&amp;nbsp; This may be through people exchanges, creation of technology demonstrators, showcase events, commercialisation workshops and ?entrepreneurs in residence? schemes.&amp;nbsp; Such exchanges of knowledge and skills will boost the most fruitful collaborations between UK universities and life science companies.</gtr:technicalSummary><gtr:fund><gtr:end>2018-02-28</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2016-03-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>250000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Centric Lab (London) Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Hugo Spiers to Centric Lab</gtr:description><gtr:id>6070CB85-A534-4610-B750-EB59B76AD33F</gtr:id><gtr:impact>Too early.</gtr:impact><gtr:outcomeId>58c671928ce442.99487264-1</gtr:outcomeId><gtr:partnerContribution>The Centric Lab PROVIDE USEABLE METRICS AND PRACTICAL INSIGHTS TO ORGANISATIONS WANTING TO BETTER UNDERSTAND HOW PEOPLE INTERACT IN A BUILT ENVIRONMENT. THEIR APPROACH IS BASED ON THE USE OF NEUROSCIENCE RESEARCH, ARCHITECTURAL DESIGN AND CULTURAL ANALYSIS. Their focus is on human experience in a given built environment allowing them to shed light for example on: Homes caring for the elderly with dementia.</gtr:partnerContribution><gtr:piContribution>Companies involved in architectural design and city planning are becoming increasingly aware of the need to account for how their designed spaces impact on health and well-being. This is particular the case in care homes for people with dementia or old age, but also generally for improving the mental health of millions of people living in congested cities. Currently, it is difficult for architects, construction companies and city planners to make use of the recent discoveries on human behaviour that come from neuroscience and psychology.
Recently, a new start up company, CENTRIC, was formed to address this need. The company have received financial backing from the construction firm ARUP and are in negotiations with other funders. The development of this company provides a useful opportunity for UCL. Research in Dr Spiers group in UCL (Experimental Psychology)
has recently focused on the interaction between neuroscience and architecture.
The aim is to establish a UCL linked research consultancy within CENTRIC which provides industry focused research experiments and advise to design and construction companies (e.g ARUP) to aid the design of cities and buildings in order to create spaces that promote well-being and support people with dementia.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Diabetes UK</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Precision Medicine Catapult</gtr:department><gtr:description>Ruth Jamieson secondment to Precision Medicine Catapult</gtr:description><gtr:id>6470D809-38AA-4D90-9F18-43B232629496</gtr:id><gtr:impact>This collaboration has already proven fruitful in its first few months. Dr Jamieson has led the scientific evaluation of Precision Medicine opportunities, while gaining new knowledge on the business and regulatory components of such projects and is currently developing the concept of a precision medicine accelerator, piloted from UCL, but open nationally to any UK SME. As such the secondment has been extended for an additional 12 months fully funded by PMC. The knowledge exchange to both organisations is helping to shape the future strategies in this important area.</gtr:impact><gtr:outcomeId>58b9a8c5cfd1c2.70733610-1</gtr:outcomeId><gtr:partnerContribution>Knowledge exchange around government policy and strategic thinking around precision medicine.</gtr:partnerContribution><gtr:piContribution>Established in April 2015, the PMC aims to make the UK a world centre for precision medicine, by providing strategic leadership for the sector, brokering links between academia, industry and government and enabling access to expertise in the collection and analysis of clinical data.
The objectives of the secondment are: ? to work with the PMC to explore, identify and assess Precision Medicine activity across the London academic, research and health landscape. ? to validate and qualify identified Precision Medicine opportunities that best meet the criteria for PMC to support and advance in line with PMC's emerging 5-year strategy and plan. ? to work with the PMC Clinical programmes team to initiate and mobilise identified and agreed priority projects in London.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Nanoco</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Elnaz Yaghini secondment to Nanoco Technologies</gtr:description><gtr:id>F2A72969-2DDA-49D6-A35D-29B4D643D71A</gtr:id><gtr:impact>Too early</gtr:impact><gtr:outcomeId>58c674f4e8dee4.28986719-1</gtr:outcomeId><gtr:partnerContribution>Nanoco will train Elnaz in nanoparticle characterisation and peptide conjugation techniques for tumour targeting.</gtr:partnerContribution><gtr:piContribution>Dr Elnaz Yaghini is an experienced biomedical researcher who will help Nanoco consolidate their new undertaking into bioscience (having just created a new bioscience division). Elnaz brings considerable expertise on tissue culture and in vivo applications of nanoparticles which will inform the Nanoco team.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">MC_PC_15063</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C4255A20-7C03-4147-BA26-8D72C9457F1C</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>HRCS Health Uncodeable</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>06E85C67-BEDD-4C93-990D-B74FCF876924</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>HRCS Research Uncodeable</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>